FM

Frazier Management Portfolio holdings

AUM $1.12M
1-Year Est. Return 151.58%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+151.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.99M
AUM Growth
-$1.3B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
43
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1 +$175M
2 +$115M
3 +$70.4M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$60.7M
5
GRTS
Gritstone bio, Inc. Common Stock
GRTS
+$60M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRA
1
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.75M 88.13%
54,654
-1,210,207
ALNA
2
DELISTED
Allena Pharmaceuticals
ALNA
$236K 11.87%
1,019,288
-632,069
GRTS
3
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
-4,667,242
ALPN
4
DELISTED
Alpine Immune Sciences Inc
ALPN
-1,784,913
ACRS icon
5
Aclaris Therapeutics
ACRS
$453M
-408,329
ARVN icon
6
Arvinas
ARVN
$785M
-163,763
AUTL
7
Autolus Therapeutics
AUTL
$402M
-3,746,857
AVDL
8
DELISTED
Avadel Pharmaceuticals
AVDL
-951,814
BCYC
9
Bicycle Therapeutics
BCYC
$350M
-555,240
COGT icon
10
Cogent Biosciences
COGT
$5.79B
-1,774,891
CRNX icon
11
Crinetics Pharmaceuticals
CRNX
$3.9B
-1,384,293
EPIX
12
DELISTED
ESSA Pharma
EPIX
-543,470
IMVT icon
13
Immunovant
IMVT
$5.09B
-585,759
PHAT icon
14
Phathom Pharmaceuticals
PHAT
$823M
-5,827,415
REPL icon
15
Replimune Group
REPL
$608M
-650,862
RGNX icon
16
Regenxbio
RGNX
$454M
-235,809
IOVA icon
17
Iovance Biotherapeutics
IOVA
$1.66B
-1,747,622
KALV icon
18
KalVista Pharmaceuticals
KALV
$850M
-1,305,087
KRYS icon
19
Krystal Biotech
KRYS
$7.31B
-771,250
MIRM icon
20
Mirum Pharmaceuticals
MIRM
$5.59B
-3,566,912
MRUS
21
DELISTED
Merus
MRUS
-559,179
PASG icon
22
Passage Bio
PASG
$24.5M
-250,461
PCVX icon
23
Vaxcyte
PCVX
$8B
-2,309,554
SLN
24
Silence Therapeutics
SLN
$347M
-886,173
SNDX icon
25
Syndax Pharmaceuticals
SNDX
$2.12B
-2,772,062